Since its launch in September 2021, Therapy Watch COVID-19 has been monitoring the ever-changing landscape of the COVID-19 treatment market. We are pleased to share that we have expanded our tracker for 2023 to include Australia, Canada, Japan, and Greece.
With these new additions, we now have a comprehensive coverage of 16 markets: US, Canada, EU5, Greece, Japan, South Korea, Singapore, Australia, Brazil, Mexico, Saudi Arabia, and Morocco.
Online interviews are conducted with a range of specialists and primary care physicians in each market. Through these interviews, we gain valuable insights into COVID-19 patients across the community, ambulatory care, or hospital settings.
By utilizing our tracker, our clients can effectively address crucial questions pertaining to COVID-19 treatment, such as:
- What is the proportion of COVID-19 patients who receive treatment? How does this vary based on the severity of disease and the patient’s risk of progression?
- Which factors drive or hinder prescription rates?
- How does the patient profile differ depending on the prescribed treatment?
- What is the patient’s treatment journey and the time taken at each stage?
Therapy Watch COVID-19 serves as an invaluable tool in monitoring the ever-evolving treatment landscape. With real-world insights, we are able to uncover the drivers behind COVID-19 prescription in each patient segment and country.
Therapy Watch is a syndicated market tracking tool that provides market researchers and marketing teams and with real-world evidence into prescribing behaviors and market dynamics.